DE69429632D1 - Dosisform mit gesteuerter freigabe für kalium - Google Patents

Dosisform mit gesteuerter freigabe für kalium

Info

Publication number
DE69429632D1
DE69429632D1 DE69429632T DE69429632T DE69429632D1 DE 69429632 D1 DE69429632 D1 DE 69429632D1 DE 69429632 T DE69429632 T DE 69429632T DE 69429632 T DE69429632 T DE 69429632T DE 69429632 D1 DE69429632 D1 DE 69429632D1
Authority
DE
Germany
Prior art keywords
micropellets
potassium
ions
tract
irritating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69429632T
Other languages
English (en)
Other versions
DE69429632T2 (de
Inventor
Chih-Ming Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andrx Pharmaceuticals LLC
Original Assignee
Andrx Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrx Pharmaceuticals LLC filed Critical Andrx Pharmaceuticals LLC
Publication of DE69429632D1 publication Critical patent/DE69429632D1/de
Application granted granted Critical
Publication of DE69429632T2 publication Critical patent/DE69429632T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69429632T 1993-10-04 1994-09-23 Dosisform mit gesteuerter freigabe für kalium Expired - Fee Related DE69429632T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/131,118 US5397574A (en) 1993-10-04 1993-10-04 Controlled release potassium dosage form
PCT/US1994/010580 WO1995009617A1 (en) 1993-10-04 1994-09-23 Controlled release potassium dosage form

Publications (2)

Publication Number Publication Date
DE69429632D1 true DE69429632D1 (de) 2002-02-14
DE69429632T2 DE69429632T2 (de) 2002-11-14

Family

ID=22447956

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69429632T Expired - Fee Related DE69429632T2 (de) 1993-10-04 1994-09-23 Dosisform mit gesteuerter freigabe für kalium

Country Status (9)

Country Link
US (1) US5397574A (de)
EP (1) EP0804172B1 (de)
JP (1) JPH09510430A (de)
AT (1) ATE211649T1 (de)
AU (1) AU678858B2 (de)
CA (1) CA2172624A1 (de)
DE (1) DE69429632T2 (de)
NZ (1) NZ274646A (de)
WO (1) WO1995009617A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
HU221435B (en) * 1998-02-20 2002-10-28 Egyt Gyogyszervegyeszeti Gyar Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
EP1244429A1 (de) * 1999-12-16 2002-10-02 Eurand America, Incorporated Kcl enthaltende tablettenformulierung mit kontrollierter freisetzung
AU2002313628A1 (en) * 2001-05-22 2002-12-03 Euro-Celtique Tamper resistant oral dosage form
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
BR0212950A (pt) * 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas tendo uma porção inserida
US6780437B2 (en) * 2001-10-23 2004-08-24 Upsher-Smith Laboratories, Inc. Coated potassium chloride granules and tablets
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
US20040156844A1 (en) * 2002-05-22 2004-08-12 Curtis Wright Tamper resistant oral dosage form
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
US8124598B2 (en) * 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
US20090181094A1 (en) * 2008-01-15 2009-07-16 Eric Yueh-Lang Sheu Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents
MX2011001384A (es) 2008-08-06 2011-09-27 Gosforth Ct Holdings Pty Ltd Composiciones y metodos para tratar trastornos psiquiatricos.
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
US20150133516A1 (en) 2013-11-13 2015-05-14 Brian K. Adams Methods and Compositions for Treating ADHD
AU2016288643A1 (en) 2015-07-02 2018-02-22 University Of Louisville Research Foundation, Inc. Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL120093C (de) * 1958-07-24
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
IT1191050B (it) * 1982-10-27 1988-02-24 Pietro Tommaso Tessitore 2(1-alchil-5-nitro)-imidazolil-1-(2-idrossi-5-alchil)-fenil-carbinoli,loro metodo di preparazione e composizioni farmaceutiche che li contengono
JPS61151109A (ja) * 1984-12-26 1986-07-09 Lion Corp 毛髪化粧料組成物
JPS61171413A (ja) * 1985-01-17 1986-08-02 Pola Chem Ind Inc 養毛料
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
CA1270765A (en) * 1985-02-19 1990-06-26 Charles Hsiao Controlled release potassium chloride
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
JPS62175417A (ja) * 1986-01-27 1987-08-01 Kanebo Ltd 養毛化粧料
JPS6396106A (ja) * 1986-10-11 1988-04-27 Shiseido Co Ltd 化粧料
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
IE60383B1 (en) * 1988-05-27 1994-07-13 Elan Corp Plc Controlled release pharmaceutical formulation
JPH02111710A (ja) * 1988-10-20 1990-04-24 Akio Fujikawa 化粧料組成物
JPH03206021A (ja) * 1990-01-08 1991-09-09 Kanebo Ltd 養毛化粧料
JP2969866B2 (ja) * 1990-08-29 1999-11-02 大正製薬株式会社 発毛剤
JPH04308523A (ja) * 1991-04-04 1992-10-30 Kanebo Ltd 養毛化粧料
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system

Also Published As

Publication number Publication date
EP0804172A1 (de) 1997-11-05
JPH09510430A (ja) 1997-10-21
CA2172624A1 (en) 1995-04-13
ATE211649T1 (de) 2002-01-15
WO1995009617A1 (en) 1995-04-13
AU678858B2 (en) 1997-06-12
EP0804172B1 (de) 2002-01-09
NZ274646A (en) 1997-02-24
US5397574A (en) 1995-03-14
AU7875794A (en) 1995-05-01
DE69429632T2 (de) 2002-11-14
EP0804172A4 (de) 1997-11-05

Similar Documents

Publication Publication Date Title
DE69429632T2 (de) Dosisform mit gesteuerter freigabe für kalium
US5891474A (en) Time-specific controlled release dosage formulations and method of preparing same
JP5068401B2 (ja) Ｈｐｍｃカプセルを使用する腸及び結腸への送達
AU2001268722B8 (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
EP1916995B2 (de) Ph-kontrolliertes pulsierendes abgabesystem, herstellungsverfahren und verwendung
US20100278912A1 (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
PT621032E (pt) Dispositivo de distribuicao de libertacao controlada de farmaco
HUT54038A (en) Process for producing compositions with hydrogel-operated controlled release of active ingredient
AU2001268722A1 (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
HUP0002056A2 (hu) Gombaellenes hatóanyaggal és polimerrel bevont magrészt tartalmazó pelletek
AU5895596A (en) Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
UY25710A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
CA2025703A1 (en) Pulsatile once-a-day delivery systems for minocycline
PT96921B (pt) Dispositivo de libertacao intermitente
Krishnaiah et al. Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis
BRPI0808801A2 (pt) Formulação farmacêutica.
Kumari et al. Formulation and Evaluation of Gastro Retentive Matrix Tablets of Sitagliptin
CA3060026A1 (en) Polymer based formulation for release of drugs and bioactives at specific git sites
KR860000070A (ko) 종양 발육억제 조성물
CA2466032A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents
KR880005944A (ko) 삼투성 연속 분배 경구용 전달 시스템
KR870002837A (ko) 지속적으로 방출되게 코오팅된 정제와 그 코오팅된 정제의 제조방법
KR20000001522A (ko) 숯을 캠슐화 또는 알약화한 건강증진 의약품
NO172834B (no) Fremgangsmaate for fremstilling av tablett med overtrekk som inneholder poredannende substans

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee